Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 1;17(12):e0277397. doi: 10.1371/journal.pone.0277397

The use of 3D digital anatomy model improves the communication with patients presenting with prostate disease: The first experience in Senegal

Babacar Diao 1,2,*, Ndèye Aissatou Bagayogo 1, Nayra Pumar Carreras 3, Michael Halle 4, Juan Ruiz-Alzola 3, Tamas Ungi 5, Gabor Fichtinger 5, Ron Kikinis 4
Editor: Yann Benetreau6
PMCID: PMC9714841  PMID: 36454858

Abstract

Objectives

We hypothesized that the use of an interactive 3D digital anatomy model can improve the quality of communication with patients about prostate disease.

Methods

A 3D digital anatomy model of the prostate was created from an MRI scan, according to McNeal’s zonal anatomy classification. During urological consultation, the physician presented the digital model on a computer and used it to explain the disease and available management options. The experience of patients and physicians was recorded in questionnaires.

Results

The main findings were as follows: 308 patients and 47 physicians participated in the study. In the patient group, 96.8% reported an improved level of understanding of prostate disease and 90.6% reported an improved ability to ask questions during consultation. Among the physicians, 91.5% reported improved communication skills and 100% reported an improved ability to obtain patient consent for subsequent treatment. At the same time, 76.6% of physicians noted that using the computer model lengthened the consultation.

Conclusion

This exploratory study found that the use of a 3D digital anatomy model in urology consultations was received overwhelmingly favorably by both patients and physicians, and it was perceived to improve the quality of communication between patient and physician. A randomized study is needed to confirm the preliminary findings and further quantify the improvements in the quality of patient-physician communication.

Introduction

Prostate diseases, represented by benign prostate hyperplasia (BPH) and prostate cancer, are the leading causes of urinary disorders of the lower tract with varying incidences depending on age, geographic regions, and ethnicity [14]. BPH is the most common of such diseases, causing high morbidity and significantly impaired quality of life. Its prevalence increases with age and, as confirmed by studies of postmortem pathology samples, reaches 70% beyond 60 years of age [5, 6]. Prostate cancer (PCa) is the most frequent cancer and the leading cancer-related cause of death in African men [7]. Early-stage PCa is often asymptomatic or shares symptoms of benign prostatic hyperplasia. While communication campaigns in Western countries have led to better knowledge and increased awareness of prostate diseases [8], but in sub-Saharan Africa, such communication traditions and techniques are lagging which makes it extremely difficult to manage patients in diagnostics, therapy, and follow-up. Patients tend to have limited knowledge of prostate diseases and are often not seen until presenting complicated or advanced disease, leading to poor therapeutic outcomes [911]. Due to lack of screening and public awareness of prostate diseases in Africa, PCa is discovered at advanced stages [12]. Sub-Saharan countries follow the same trend, although reliable national statistics on prostate diseases are scarcely available due to a lack of adequate recordkeeping [13]. In Senegal, over 60% of patients present with advanced cancer and only less than 40% with treatable localized disease [1416], a stark contrast to the USA where about 89% of PCa are diagnosed early [17]. Alas, the five-year survival rate after diagnosis hovers around 30% in Senegal [16], versus 98% in the USA [17].

This paper concerns physician-patient communication consultation in urology setting, specifically regarding prostate disease. It has been well understood that effective patient-physician communication can improve a patient’s health quantifiably, and in turn, it reduces healthcare costs [18], Patients who understand their doctors are more likely to acknowledge health problems, understand their treatment options, modify their lifestyle and behavior accordingly, and follow prescribed treatment regimen; ultimately leading to more favorable clinical outcomes [19].

We hypothesized that the use of 3D digital anatomy models would be received favorably by both physicians and patients, and in turn, it would improve the quality of communication during consultation between physicians and patients presenting with prostate disease. The purpose of this exploratory study was to demonstrate the technical feasibility of using 3D digital anatomy models in Senegal and gauge the perception of this technology by both physicians and patients and its potential impact of this technology on the quality of communication between physicians and patients.

Methods

3D digital anatomy model

The 3D digital anatomy model of the prostate was based on McNeal [20, 21] zoning that divides the prostate into five areas where tumors usually develop: peripheral zone where 70% of prostate cancers grow; transition zone where BPH develops and 30% of cancers grow; central zone with the ejaculating channels; peri-urethral zone where BPH initiates; and anterior fibromuscular zone. The urethra and rectum were included to help explain the nature of impaired urinary flow and digital rectal examination (DRE), respectively.

For this exploratory study, we selected a single representative case, deemed similar many of the cases seen in initial urology consultation in Senegal. Multiparametric MRI of a 62 y.o. man, presenting with urinary disorder of the lower tract, PSA over 13 ng/ml, negative biopsy, was acquired, with 1.5T Siemens scanner, 3mm slice thickness. The MRI showed PI-RADS 1 lesions with an enlarged transition zone. The MRI scan was imported in DICOM format to the 3D Slicer free open-source medical image visualization software [22, 23], running on a laptop. The McNeal zones, urethra, and rectum were manually contoured (Fig 1).

Fig 1. MRI images with segmentation of labels, in the mid-section of the prostate.

Fig 1

The resulting 3D digital anatomy model (Fig 2) was saved for subsequent viewing in 3D Slicer on a laptop, tablet, or desktop computer, with convenient functions to zoom in/out, rotate and selectively show/hide structures, similarly to most other existing digital anatomy viewers [24]. The participating physicians received an introductory training on the use of the 3D Slicer interactive software to visualize the 3D digital anatomy model on their own office computer.

Fig 2. Screen capture of the 3D digital anatomy model, showing McNeal zones.

Fig 2

Study design

We conducted a single-arm prospective qualitative study of preliminary and exploratory nature, to gauge technical feasibility and the perception of this technology by both physicians and patients.

The study involved patients referred for urological consultation, presenting with symptoms or concerning findings in the lower urinary tract, attributed to suspected prostate disease. The physician group consisted of attending staff and clinical residents specializing in urology or general medicine, experienced in consulting patients presenting with prostate disease. During the urology consultation, each patient first received an explanation of his suspected prostate disease using conventional means, including manual drawings and verbal explanation, as usually done by the given physician. We did not provide a “standardized” drawings or didactic images for the physicians who conducted the consultation according to their own usual practice. Next, informed consent was sought from the patient for participation in the study. If the patient opted in to participate, a second explanation of the suspected disease followed, this time using the 3D digital anatomy model rendered on the computer. At the end of the consultation, the patient was asked to fill out a straightforward questionnaire, shown in Table 1, about his overall experience with the quality of the consultation. Upon completing the study, each participating physician was asked to fill out a similarly straightforward questionnaire, shown in Table 2, about their own experience with consultation and the effects of using 3D digital anatomy model.

Table 1. Questionnaire for patients (with 95% confidence intervals (CI) from/to).

Questionnaire for patients Numbers Percent CI from CI to
Q1. How was your level of understanding impacted by the computer model?
    • Improved 298 96.8% 95% 99%
    • No change 10 3.2% 1% 5%
    • Decreased 0 0%
Q2. Was your decision about treatment impacted?
    • Yes 222 72% 67% 77%
    • No 86 28% 23% 33%
Q3. If yes, which method impacted your decision?
    • Computer model 194 87.4% 84% 91%
    • Manual drawing 28 12.6% 9% 16%
Q4. Did computer model help you ask more questions?
    • Yes 279 90.6% 87% 94%
    • No 29 9.4% 6% 13%

Table 2. Questionnaire for physicians (with 95% confidence intervals (CI) from/to).

Questions for physicians Numbers Percent CI from CI to
Q1. Did your communication skill improve by using the computer model?
    • Yes 43 91.5% 88% 95%
    • No 4 8.5% 5% 12%
Q2. Did obtaining consent to treatment improve by using the computer model?
    • Yes 47 100% 100% 100%
    • No 0 0 0% 0%
Q3. Was the length of communication reasonable with using the computer model?
    • Yes 11 23.4% 19% 28%
    • No, it takes too long 36 76.6% 72% 81%
Q4. Are you likely to encourage your colleagues to consider using the computer model?
    • Yes 47 100% 100% 100%
    • No 0 0 0% 0%

The questions were purposefully designed to be short and straightforward, for two main reasons. First, the participating patients were members of the general public, with varying and typically limited educational background; we tried to avoid “participant fatigue” and not to overwhelm the patient. Secondly, we tried not to increase excessively the overall length of consultation.

The questionnaires, as all documents in relation to this trial, were originally written in French and then translated to English for the purpose of this article.

Statistical analysis

Confidence intervals were computed as follows. With confidence level of 0.95, alpha = 0.025, so Z = 1.96. The formula for confidence interval is: p-1.96*sqr(p*q/n) and p+1.96*sqr(p*q/n), where p is the sample proportion, q = 1-p, and n is the sample size.

Chi-square test of independence was performed to analyze the relation between referral groups and different responses in the questionnaire. Bonferroni correction was applied to compensate for repeated tests.

Research ethics approval

This study was approved by the institutional human research ethics board of the Ouakam Military Hospital, Dakar, Senegal, as the principal performance site with additional satellite clinics. Participating patients gave signed consent, stating their understanding that the study was voluntary and conducted anonymously for research purposes. Patients were assured that no aspect of the study was included in their medical record. No specific incentives were offered to study participants, neither patients nor providers. During the informed consent process, however, patients were informed about potential benefits, such as receiving more detailed information about their disease and condition and additional “face time” with their consulting physician.

Study period

This study took place between March 1, 2019 and June 30, 2019.

Referral groups

A total of 47 physicians took part. Enrollment was offered to 387 patients, of whom 308 gave informed consent and participated in the study.

Each participating patient belonged to one of the following major referral groups:

  • First-time consultation: 106 patients were seen for a first-time consultation, for whom it was necessary to explain the benefits and nature of DRE.

  • Biopsy candidates: 74 patients were seen because it was recommended that they have a prostate biopsy based on previous DRE and/or high PSA.

  • Watchful waiting candidates: 37 patients were seen because they had had a previous negative core needle biopsy of suspected cancer, for whom it was necessary to explain why they were not guaranteed to be free of cancer and why they needed regular follow-ups.

  • Prostatectomy candidates: 29 patients were seen for positively diagnosed prostate cancer and who had been recommended to have radical prostatectomy.

  • TURP candidates: 62 patients were seen for BPH with associated urinary symptoms, who were likely to require eventual surgical management.

Patient demographics (age, etc.) was not collected in this exploratory study.

Results

Answers to the questionnaires

In all, 308 patients and 47 physicians participated and filled out their questionnaires. The mean age of patients was 69.6 ± 6.7 years (46–98 years). Patient and physician experiences with the 3D digital anatomy model were reported in Tables 1 and 2, respectively.

Patient answers (see Table 1):

  • Q1: 96.8% of patients found that their level of understanding of the disease and subsequent treatment options had improved, while only 3.2% reported no change in understanding. No patient reported a decrease.

  • Q2: 72% of patients found that their decision regarding further management of the disease was impacted by the consultation, and (Q3) 87.4% of these patients found that the use of the 3D digital anatomy model impacted their decision, versus 12.6% who found the manual drawing to be more impactful.

  • Q4: 90.6% of patients found that the 3D digital anatomy model improved their ability to ask questions about treatment and follow-up.

Physician answers (see Table 2):

  • Q1: 91.5% of physicians found that the use of the 3D digital anatomy model improved their communication skills, versus 8.5% who reported it to be unaffected.

  • Q2: 100% of the physicians found that their ability to obtain patient consent for subsequent treatment and follow-up improved by using the 3D digital anatomy model.

  • Q3: 76.6% of the physicians felt that the use of the 3D digital anatomy model added too much time to the consultation.

  • Q4: 100% of the physicians were likely to encourage their colleagues to consider using 3D digital anatomy models.

Statistical considerations

All answers given by 308 patients and 47 physicians to all questions, excluding one, were decisively positive; the single negatively answered question had over 76% majority. In this light, succinct descriptive statistics were deemed satisfactory for this exploratory study. On average, each physician saw 6–7 patients, a sufficiently large enough pool to capture the essence of their experiences in a statistically suggestive manner.

The 95% confidence intervals for the patient and physician questionnaires are provided in right-most columns of Tables 1 and 2, respectively.

Reported in Table 3, we broke down the patient answers by referral groups. At our sample size and significance level of 5%, we did not find significant differences between referral groups in answering Q1. Patients who visit for their first consultation found that their treatment decision was less often impacted (Q2), the computer model was less impactful in their decisions (Q3), and the computer model less often helped them ask more questions (Q4) compared to patients who come for a follow-up visit (p<0.001 for Q2, Q3, and p = 0.04 for Q4).

Table 3. Questionnaire for patients, broken down by referral groups.

First consultation (106) Biopsy candidates (74) Watchful-waiting candidates (37) Prostatectomy candidates (29) TURP candidates (62) Chi2 p value
Q1. How was your level of understanding impacted by the computer model? p = 0.69
    • Improved (298) 101(95.3%) 72(97.3%) 37(100%) 28(96%) 60(96.8%)
    • No change (10) 5(4.7%) 2(2.7%) 0 1(3.4%) 2(3.2%)
    • Decreased 0 0 0 0 0
Q2. Was your decision about treatment impacted? p<0.01
    • Yes (222) 59(55.7%) 66(89.2%) 26(70.3%) 23(79.3%) 48(77.4%)
    • No (86) 47(44.3%) 8(10.8%) 11(29.7%) 6(20.7%) 14(22.6%)
Q3. If yes, which method impacted your decision? p<0.01
    • Computer model (194) 39(66.1%) 63(95.5%) 26(100%) 23(100%) 43(89.6%)
    • Manual drawing(28) 20(33.9%) 3(4.5%) 0 0 5(10.4%)
Q4. Did computer model help you ask more questions? p = 0.04
    • Yes (279) 88(83%) 74(100%) 33(89.2%) 29(100%) 55(88.7%)
    • No(29) 18(17%) 0 4(10.8%) 0 7(11.3%)

Discussion

The most important finding is that, in our experience, the use of a 3D digital anatomy model was perceived to improve the quality of communication for both patients and physicians in all aspects addressed by the questionnaires.

Impact on patients

Improvement in the quality of communication from the perspective of patients is reflected by the questionnaire in Table 1: better understanding explanations (Q1), positive impact on treatment decisions (Q2, Q3), and increased number of questions asked (Q4).

Understanding explanations

In Senegal, where patients have a low level of literacy, understanding the nature of prostate diseases seems to have been facilitated by the 3D digital anatomy model. In the long run, this should help patients to participate and stay engaged in their disease management. Over the past decade, several studies across Africa have revealed a low level of knowledge and awareness of prostate cancer [2530]. A tool that facilitates the communication and understanding of prostate diseases could be beneficial in improving the quality of care and reducing healthcare costs. According to Bennett et al. [31], low literacy level can be a significant barrier to early diagnosis of prostate cancer among low-income patients in America, and it is safe to assume that this is true throughout sub-Saharan Africa. It follows that appropriate communication strategies would improve awareness of prostate disease and promote earlier diagnosis. This, in turn, would reduce costs associated with the complex treatment of advanced diseases.

Impact on treatment decisions

The discussion with the patient for consenting to treatment is especially important when they present with high-risk disease, such as prostate cancer. The need to consider and accommodate the patient’s preferences for disease management has long been the cornerstone of communication between physician and patient [32] and the use of a 3D digital anatomy model seemed helpful in this regard.

Table 3 shows that, on the whole patients favored of the digital model regardless of the reference group. However, the differences were less significant in decision-making for first-time consultants and patients monitored by watchful waiting. At the same time, the differences were much more significant in decision-making for “high-risk” patient groups, especially the biopsy candidate group, who needed immediate management of the disease.

Ability to ask questions

Encouraging patients to ask well-informed questions should help them understand not only the benefits, but also the risks of treatment. The quality of physician-patient communication has direct impact on managing expectations and post-treatment grievances [33]. In our study, the use of a 3D digital anatomy model allowed the patient to better understand the risks and potential consequences of procedures, whether biopsy, radical prostatectomy or TURP. With just a few simple mouse clicks on the computer, physicians were able to explain complicated concepts, like the mechanism of DRE as an important diagnostic tool, or what radical prostatectomy involves in relation to functional outcomes, or the need for regular follow-ups after a negative biopsy. Lack of understanding of basic health information has had a well-documented negative impact on health care [34] and thus, the importance of making advances in patient education cannot be underestimated. Our preliminary study suggests that a modest or low level of literacy and knowledge of prostate diseases is not an insurmountable obstacle, and that the gap can be bridged by improved communication, in which the use of a 3D digital anatomy model appeared to be decidedly helpful. In this regard, our findings are consistent with Rajbabu et al. [35], who found that low levels of income and literacy are associated with poor awareness of prostate cancer, but that this situation may be improved by effectively conveying information about the nature of the disease and its management.

The mean age of patients was 69.6 ± 6,7 years in this exploratory study. In Senegal, men younger than 55 years of age are seldom seen in urology consultation. Practically speaking, nearly all patients who participated in our study were born before the “digital age”, and they were likely to have been affected similarly by the “novelty factor” of digital anatomy technology, regardless of their exact age.

Impact on physicians

The benefits of using a 3D digital anatomy model, from the perspective of physicians, is reflected by their answers to the questionnaire shown in Table 2: improved communication skills (Q1), improved ability to obtain consent to treatment (Q2), and high likelihood of encouraging colleagues to adopt this new technology (Q4), while criticism was expressed for lengthening the consultation (Q3).

Communication skills

Communication techniques are not taught in medical school in Senegal. The use of an interactive 3D digital anatomy model represents not only innovation but is also a tool to guide and help the physician in conveying information to the patient, thus facilitating communication. It can also be a useful tool for the physician to emphasize certain aspects of the disease and to finetune communication of the patient’s specific needs in consideration of his symptoms and prostatic pathology.

Obtaining consent to treatment

Our findings were consistent with existing literature. Our 3D digital anatomy model can be considered conceptually similar to the cartoon illustrations proposed by Delp et al. [36], which were found to improve adherence to treatment. Haskard Zolnierek et al. [37] found that the risk of non-adherence to treatment by patients increases by 19% when the physician does not communicate well with the patient, and the chances of adherence are 1.6 times higher when the physician has undergone communication training.

Lengthening the consultation

The increased length of the consultation, which was reported by the majority of physicians, is a significant concern. Simple didactic anatomic pictures play a similar role and they take less time. During the first part of the consultation session the physicians used some didactic anatomical pictures of their own design and drawing. Nonetheless, both physician and patients uniformly reported favorable experience from additionally using 3D digital anatomy models. Hence in this paper we argue that the use of 3D digital models may help improve upon the quality of patient-physician communication.

This could be explained by that fact that using interactive 3D anatomy model is a novelty for both parties. Over 90% of patients found that the 3D digital anatomy model improved their ability to ask questions, and more questions always lead to longer consultations. For physicians, the 3D digital anatomy model is a new technology that involves a learning curve; it is quite probable that the length of each consultation would be reduced as physicians become more proficient in using this technology on the computer. Moreover, the use of the 3D Slicer software adds complexity and can be confusing for novice users and may require extra time to use during consultations. However, one can argue that, in contrast to the current practice, the increase in the length of consultations may be well-compensated by the gain in the quality of communication, and in turn, in the quality of care.

Encouraging colleagues to adopt the technology

The willingness, unanimously expressed by physicians in this study, to popularize the use of 3D digital anatomy models reinforces the hope that this technology will be well-appreciated by its physician users.

Limitations

Study design

In this single-arm exploratory and preliminary study, with each patient we conducted two urological consultations, back-to-back: first a conventional consultation session that was immediately followed by a session using 3D digital anatomical models, and then we gauged the perceived improvement on the quality of the physician-patient communication through simple questionnaires.

The ultimate objective of improving physician-patient communication is to improve patient willingness to pursue further care and sustained compliance with the prescribed follow-up regimen, a crucially important aspect for all patients with prostate disease. Although this could not be measured in this short preliminary study, existing literature supports our expectation that improved patient-physician communication should lead to improved patient compliance in general [37]. In follow-up work, we plan to run a randomized study with two arms of patients, one receiving conventional consultation and one receiving consultation with using 3D digital anatomical models. This future study would allow us to compare clinical outcome variables, such as willingness to pursue further care, etc.

Choice of questionnaires

We used simple binary questions to gage various aspects in patient and physician experience with the 3D digital anatomy model, with respect to the quality of communication during consultation. We considered the use of scaled feedback, even as simple as Likert scales, and decided not to follow that approach. As our patients have a very modest level of literacy, they could have been easily overwhelmed by more complicated questions involving concepts like “scale” or “percentage”. The physicians, however, could have been asked more nuanced questions, and this will be considered in future studies.

In this exploratory study, we intended to size up the perception of participant, rather than more objectively assessing knowledge and experience gained by the participants through using of 3D digital anatomy models and whether the actual communication skills of the physician is improved, for which we will need to capture and analyze what is actually said and communicated to the patients; all this, however, we were compelled to reserve for future work. In further follow-up work, in the randomized dual-arm study mentioned earlier above, we would construct the questionnaires differently and would also break down the results by referral groups; it is suspected that patients with benign and malignant conditions may react to the outcome of urological consultation differently and thus may differ in their willingness to pursue further care.

Choice of the 3D anatomical model

The 3D digital model was not personalized based on the individual patient case, for this is not possible in Senegal, for multiple reasons. For many patients, the consultation session studied in this paper was the first meeting between the physician and the patient upon referral, when practically no Senegalese patient has prior imaging scan of any sort. Moreover, due to general lack of imaging capacity, especially that of MRI. In future work, we consider creating several anatomical models, and based on a quick digital rectal examination, the physician could select the one that feels the most similar one to the prostate of the given patient.

Choice of digital anatomy viewing software

During the urology consultation, the 3D digital anatomy model was viewed with the free, open-source 3D Slicer software [22, 23]. 3D Slicer is an extremely powerful and complex research platform for medical image analysis and visualization, offering over 1,000 major functions in its core, and fortified by over 100 extension packages. The use of 3D Slicer for the sole purpose of visual rendering may have been overly complex for new users, and it was probably the most important reason why over 76% of the physicians felt that using the 3D digital anatomy model lengthened the consultation exceedingly. In future work, we consider using the Open Anatomy Browser [22], another free open-source digital anatomy viewing platform that is much simpler to learn and operate, which, in turn, should help reduce the length of the consultation session without loss of effectiveness. Moreover, the Open Anatomy Browser visualizes 3D digital anatomy model created in 3D Slicer, allowing is to reuse previously created models. The Open Anatomy Browser works through a public web interface, accessible from mobile device, such as smart phone, that practically all Senegalese physicians possess. Finally, the simple user interface of the Open Anatomy Browser may allow patients to review on their own mobile device the main points of the consultation with their family and their referring physician.

Robustness of findings over time

One significant limitation of this study was the 4-month duration, a time frame insufficient to ascertain the consistency and robustness of our findings over time, particularly of the enthusiasm of doctors to use the 3D digital anatomy model and their desire to popularize it among their colleagues. It is possible that part of their enthusiasm was generated by the appealing technological novelty and the fact this study was the first of its kind in Senegal and, according to our knowledge, in sub-Saharan Africa.

Relationship to public awareness of prostate disease

The work presented here is not a “community intervention” on awareness, but rather can be considered as a “clinical intervention” following initial referral for consultation. Increasing the awareness of prostate disease and improving the management of the disease (including patient-physician communication, the subject of this paper) must go hand in hand. In Senegal, we promote the awareness of prostate disease to the public through the annual Prostate Disease Awareness Day (PDAD), a sweeping outreach effort in the Senegalese media and social platforms. Participating media outlets include the Senegalese National Television, 4 private television networks, 6 radio stations, and 2 major social platforms. PDAD provides not only general information to the public, but also free, walk-in urology consultation for ad-hoc patients. In Dakar alone, over 60 participating physicians (urologists and general practitioners) provide free clinical consultation during PDAD.

Conclusion

In this exploratory study, we found that the use of a 3D digital anatomy model in urology consultations was received favorably by both physicians and patients. It was perceived to improve the quality of communication between patient and physician, and both parties reported an overwhelmingly positive experience. Further studies are required to quantify these preliminary qualitative findings. Although this study concentrated on prostate diseases, the same technology should translate to other important areas, such as women’s and maternal health, which are among the most pressing health problems in sub-Saharan African countries.

Supporting information

S1 Data

(XLS)

S2 Data

(XLS)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Kok ET, Schouten BW, Bohnen AM, et al. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study. J Urol. 2009;181(2):710–716. doi: 10.1016/j.juro.2008.10.025 [DOI] [PubMed] [Google Scholar]
  • 2.Taylor BC, Wilt TJ, Fink HA, et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68(4):804–809. doi: 10.1016/j.urology.2006.04.019 [DOI] [PubMed] [Google Scholar]
  • 3.Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction appears in CA Cancer J Clin. 2020 Jul;70(4):313]. CA Cancer J Clin. 2018;68(6):394–424. [DOI] [PubMed] [Google Scholar]
  • 4.Sadeghi-Gandomani HR, Yousefi MS, Rahimi S. et al. The incidence, risk factors, and knowledge about the prostate cancer through worldwide and Iran. WCRJ 2017; 4 (4): e972 [Google Scholar]
  • 5.Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132: 474–9. doi: 10.1016/s0022-5347(17)49698-4 [DOI] [PubMed] [Google Scholar]
  • 6.Guess HA, Arrighi HM, Metter EJ, et al. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate 1990; 17: 241–6. - doi: 10.1002/pros.2990170308 [DOI] [PubMed] [Google Scholar]
  • 7.Adeloye D, David R A, Aderemi A V, et al. An Estimate of the Incidence of Prostate Cancer in Africa: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(4):e0153496. doi: 10.1371/journal.pone.0153496 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.MacDonald S, Macleod U, Campbell NC, et al. Systematic review of factors influencing patient and practitioner delay in diagnosis of upper gastrointestinal cancer. Br J Cancer. 2006; 94(9):1272–1280 doi: 10.1038/sj.bjc.6603089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ajape A, Babata A, Abiola O. Knowledge of prostate cancer screening among native African urban population in Nigeria Nigerian Quarterly Journal of Hospital Medicine, 2010; 20 (2): 94–96. [DOI] [PubMed] [Google Scholar]
  • 10.Ravichandran K, Mohamed G, Al-Hamdan N. Public knowledge on cancer and its determinants among Saudis in the Riyadh Region of Saudi Arabia. Asian Pac J Cancer Prev. 2010; 11(5):1175–1180. [PubMed] [Google Scholar]
  • 11.Forbes L, Simon AE, Warburton F. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? Br J Cancer. 2013; 108(2):292–300. doi: 10.1038/bjc.2012.542 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Cassell A, et al. A Review of Localized Prostate Cancer: An African Perspective. World J Oncol, 2019. Oct;10(4–5):162–168. doi: 10.14740/wjon1221 . PMCID: PMC6785274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Seraphin TP, et al. Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 2021. Nov 15;127(22):4221–4232. doi: 10.1002/cncr.33818 Epub 2021 Jul 30. . [DOI] [PubMed] [Google Scholar]
  • 14.Niang L, et al. Screening for Prostate Cancer by Digital Rectal Examination and PSA Determination in Senegal. ISRN Oncol. 2011; 2011:943704. doi: 10.5402/2011/943704 . PMCID: PMC3196002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Ndoye AK, et al. Advanced prostate cancer in Senegal. Prog Urol. 2014. Apr;24(5):271–5. doi: 10.1016/j.purol.2013.08.317 . [DOI] [PubMed] [Google Scholar]
  • 16.Diallo Y, et al. Metastatic Prostate Cancer: Clinical Aspects and Therapeutic Management in the Region of Thies Senegal. Medical & Surgical Urology, Volume 8, Issue 4, 2019. [Google Scholar]
  • 17.American Society of Clinical Oncology (www.cancer.net), Prostate Cancer: Statistics, 2021
  • 18.Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;15(9):1423–1433. [PMC free article] [PubMed] [Google Scholar]
  • 19.Travaline JM, et al. Patient-physician communication: why and how. J Am Osteopath Assoc. 2005; 105(1): 13–18. [PubMed] [Google Scholar]
  • 20.McNeal J E. The Zonal anatomy of the prostate. Prostate 1981; 2:35–49 doi: 10.1002/pros.2990020105 [DOI] [PubMed] [Google Scholar]
  • 21.McNeal J E. Normal histology of the prostate. Am J SurgPathol 1988; 12:619–33 [DOI] [PubMed] [Google Scholar]
  • 22.Kapur T, Pieper S, Whitaker R, et al. The National alliance for medical image computing, a roadmap initiative to build a free and open source software infrastructure for translational research in medical image analysis. J. Am. Med. Information. Assoc.2012; 19:176–180. doi: 10.1136/amiajnl-2011-000493 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an Image Computing Platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012; 30(9): 1323–1341. doi: 10.1016/j.mri.2012.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Halle M, Demeusy V, Kikinis R. The Open Anatomy Browser: A Collaborative Web-Based Viewer for Interoperable Anatomy Atlases. Front Neuroinform 2017; 11: 22. doi: 10.3389/fninf.2017.00022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kabore FA, Kambou T, Zango B, Ouédraogo A. Knowledge and awareness of prostate cancer among the general public in Burkina Faso. J Cancer Educ. 2014;29(1):69–73. doi: 10.1007/s13187-013-0545-2 [DOI] [PubMed] [Google Scholar]
  • 26.Agbugui JO, Obarisiagbon EO, Nwajei CO, et al. Awareness and knowledge of prostate cancer among men in Benin city, Nigeria. Journal of Medicine and Biomedical Research. 12. 42–47. [Google Scholar]
  • 27.Korir A, Okerosi N, Ronoh V, et al. Incidence of cancer in Nairobi, Kenya (2004–2008). Int J Cancer. 2015;137(9):2053–2059. doi: 10.1002/ijc.29674 [DOI] [PubMed] [Google Scholar]
  • 28.Mohamed M, Suad M. Assessment of knowledge, attitude and practice of males about prostate cancer, screening and early detection in east Nile locality, Khartoum Sudan, International Journal of Current Research. 2015; 7(12): 24311–24315. [Google Scholar]
  • 29.Nakandi H, Kirabo M, Semugabo C, et al. Knowledge, attitudes and practices of Ugandan men regarding prostate cancer. Afr J Urol. 2013;19(4):165–170. doi: 10.1016/j.afju.2013.08.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mofolo N, Betshu O, Kenna O, et al. Knowledge of prostate cancer among males attending a urology clinic, a South African study. Springerplus. 2015;4:67. doi: 10.1186/s40064-015-0824-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bennett CL, Ferreira MR, Davis TC, et al. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998;16(9):3101–3104. doi: 10.1200/JCO.1998.16.9.3101 [DOI] [PubMed] [Google Scholar]
  • 32.Bowling A, Ebrahim S. Measuring patients’ preferences for treatment and perceptions of risk. Qual Health Care. 2001;10 Suppl 1(Suppl 1):i2–i8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Levinson W, Roter DL, Mullooly JP, et al. Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons. JAMA. 1997;277(7):553–559. doi: 10.1001/jama.277.7.553 [DOI] [PubMed] [Google Scholar]
  • 34.Rasu RS, Bawa WA, Suminski R, et al. Health Literacy Impact on National Healthcare Utilization and Expenditure. Int J Health Policy Manag. 2015;4(11):747–755. doi: 10.15171/ijhpm.2015.151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Rajbabu K, Chandrasekera S, Zhu G, et al. Racial origin is associated with poor awareness of prostate cancer in UK men, but can be increased by simple information. Prostate Cancer Prostatic Dis. 2007;10(3):256–260. doi: 10.1038/sj.pcan.4500961 [DOI] [PubMed] [Google Scholar]
  • 36.Delp C, Jones J. Communicating information to patients: the use of cartoon illustrations to improve comprehension of instructions. Acad Emerg Med. 1996;3(3):264–270. doi: 10.1111/j.1553-2712.1996.tb03431.x [DOI] [PubMed] [Google Scholar]
  • 37.Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–834. doi: 10.1097/MLR.0b013e31819a5acc [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Joseph Donlan

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

20 Jun 2022

PONE-D-21-12063The use of 3D digital anatomy model improves the quality of communication with patients presenting with prostate disease, first experience in SenegalPLOS ONE

Dear Dr. Diao,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your manuscript has been assessed by three expert reviewers, whose comments are appended below. The reviewers have highlighted concerns about several aspects of the methodology and discussion. Please ensure you respond to each point carefully in your response to reviewers document, and modify your manuscript accordingly.

Please submit your revised manuscript by Aug 04 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Joseph Donlan

Editorial Office

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified whether consent was informed.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: "Financial support:  U.S. NIH/NIBIB 5P41EB015902-22, U.S. NIH/NIBIB 3P41EB015902-21A1S1, U.S. NIH/NIMH 1R01MH112748-03, BWH Precision Medicine Pilot Research Award, EU INTERREG MAC Program (MAC/1.1b/098), Natural Sciences and Engineering Research Council of Canada, U.S. NIH/NIBIB P41EB015898-15, U.S. NIH/NCI 1R01CA235589-01A1."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "The authors received no specific funding for this work"

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: No

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript is simple but informative. Also the results are expected.

The number of patients and physicians accessed was reasonable.

While any image is better than no image, I would add simple anatomic figures to be more comprehensive to patients.

It is a huge challenge the fact that "76.6% of physicians complained that using the computer model lengthened the consultation."

This might reflect the complexity and inaccuracy of utilized model and interface (computer).

In our practice, simple and didactic anatomic pictures on the physician's office wall play similar role, certainly taking less time.

Reviewer #2: This manuscript presents the use of a 3D digital anatomy model of the prostate to help improve patient-provider communication in Senegal. While the concept is quite interesting, this study lacks depth and clarity. This manuscript could be strengthened with major revisions. Below, are outline comments by sections.

Introduction

• Should identify more current statistics on worldwide rates of prostate cancer deaths.

• It is unclear how “sociocultural realities that render prostate disease a taboo subject” is ameliorated or even considered in the context of this intervention. It is also unclear how this intervention has the potential to impact limited knowledge of prostate disease that are often not seen until presented complicated or as advanced disease. This is not a community intervention on awareness, but rather a clinical intervention after clinical presentation.

• This authors must reconsider what is important to present as relevant background information for this study.

• Given the preliminary and exploratory nature of this study, this should be stated clearly upfront.

Methods:

• Given the discussion of the 3D digital anatomy model section, it is unclear if a standard image was shown to all patients in the study, or if the image was personalized based on the individual patient case. It is unclear why there is a section on a specific patient case of a 62 year old man.

• Under study design, authors indicate “patient first received … standard manual drawings, followed by … 3D digital…” What is the standard manual drawing based on? Is it just what the physician was able to draw themselves or a pre-drawn out image on a paper? More detail is needed for clarity.

• The questions are quite limited in nature and should be addressed in a limitations section.

• What, if any, incentives were provided to study participants – whether patients or providers?

Results

• A comparison/usual care group could be much more informative and insightful, along with more detailed questions to assess quality of communication, understanding, communication skills, etc., even for low literacy groups, with low response burden.

• Authors should be more clear that the questions assess perception/perceived point of view. For example, asking about improved level of understanding as improved or declined, is perceived and not objective as asking actual questions that assess knowledge. This should also be acknowledged in a limitations section.

Discussion

• Authors should rephrase discussion section and conclusions drawn to be more accurate. For example, quality was not assessed and the conclusion that quality of communication improved is not accurate. There was no comparison group to show an improvement, nor a pre/post questionnaire, for example.

• Impact on physicians – There is also extreme over simplification of communication skills. Nothing that was presented in the intervention dealt with communication – e.g., what is actually said/communicated to patients. This 3D image is a visual “tool” that has the potential to enhance communication, but that was not measured in this study, but rather participants’ perspective on usability or utility, and even that is quite limited in the 4 questions asked of patients and providers.

• Statistical significance – It is unclear why there is a section on statistical significance when this study was exploratory in nature and only presented descriptive statistics. This section seems inappropriate.

• The additional subheadings following the discussion section is confusing, when some appear to be appropriate for the methods section.

• Digital software – what is the difference between the two platforms mentioned, besides one being free? Why bring this up as an option?

• The section on longevity of findings also seem inappropriate and inaccurate given the nature of this study.

Reviewer #3: The manuscript represent the result of a survey on the use of a 3D digital anatomy model in urology consultation to reflect its effect on improving the communication of physician and patients. An interesting model used in this study which based on the results of the survey demonstrated an improved communication between physicians and patients. However, I do not believe the survey results are presented and discussed properly. in more detail (e.g. consider results in referral groups and).

1. It is not clear if patients information such as age is collected in the survey. If it has been collected, the results should be reported and investigated in terms of any association with age groups (e.g. elderly patients might gain less benefit from the technology compared to younger patients). Otherwise, it should be mentioned that age of patients are not recorded in survey with a discussion on the reason.

2. There is no statistical method applied to investigate the result of the survey. Authors need to apply statistical methods to add the uncertainty associated with the reported percentage (e.g. in terms of confidence intervals). Also the chi-square or other relevant tests should be applied to investigate the association of each questionary with available patient groups (referral group, age groups, etc).

3. Authors need to report results of the questionaries in the survey by the referral groups and investigate any association between referral groups and each questionary (e.g. different treatment usually are recommended for patients with different group so it would be interesting to consider how patients’ decision has changed regarding their referral group).

4. Impact on patients in discussion, it is mentioned that “A tool that facilitates the communication and understanding of prostate diseases could be beneficial in improving the quality of care and reducing healthcare costs”. However, it is not well discussed how such a tool could reduce healthcare cost, and I suggest authors to add a discussion justifying this. (lines 168-170)

5. They mentioned that the use of such a 3D digital anatomy model is helpful for treatment decision of high-risk patients. It is not clear how the presented results are supporting such a statement! A clear discussion needs to be added including how the patients decisions are improved by use of such a 3D digital anatomy model. (lines 177-182)

6. Some of subsections in the discussion should be moved and presented in the Method section (i.e. Statistical significance, Choice of questionnaires and Choice of digital anatomy viewing software).

7. It is not clear how such a software would be available to be used in the clinical practices if required.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Leonardo Oliveira Reis

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 1;17(12):e0277397. doi: 10.1371/journal.pone.0277397.r002

Author response to Decision Letter 0


13 Sep 2022

Response to the Reviews

We thank the editor and the reviewers for the helpful comments. Our point-by-point responses below detail the revisions.

Reviewer 1

The changes addressing these comments are marked by green color in the revised manuscript.

Comment: The manuscript is simple but informative. Also the results are expected.

Answer: Thank you for this positive comment. We were indeed glad to see that our results support the hypothesis. [No editing is required to address this comment].

Comment: The number of patients and physicians accessed was reasonable.

Answer: Thank you for this positive comment. [No editing is required to address this comment].

Comment: While any image is better than no image, I would add simple anatomic figures to be more comprehensive to patients…. In our practice, simple and didactic anatomic pictures on the physician's office wall play similar role, certainly taking less time.

Answer: We agree, while noting that in our study, during the first part of the consultation session the physicians used some didactic anatomical pictures of their own design and drawing. Nonetheless uniformly reported favorable experience from additionally using 3D digital anatomy models. Hence in this paper we argue that the use of 3D digital models may help improve upon the quality of patient-physician communication. We emphasize this in the revised text. [See in Methods / Study Design]

Comment: It is a huge challenge the fact that "76.6% of physicians complained that using the computer model lengthened the consultation. This might reflect the complexity and inaccuracy of utilized model and interface (computer).

Answer: We agree that lengthening the consultation session is indeed a significant concern. The use of 3D digital models doubtless adds complexity which in turn adds time to the consultation. In the revised Discussion section, we propose ways to mitigate this effect, such as using a simpler digital anatomy viewing software. [See in Discussion / Impact on physicians]

Reviewer 2

The changes addressing these comments are marked by red color in the revised manuscript.

Comment: This manuscript presents the use of a 3D digital anatomy model of the prostate to help improve patient-provider communication in Senegal. While the concept is quite interesting, this study lacks depth and clarity. This manuscript could be strengthened with major revisions.

Answer: We agree and carried out substantial revisions to improve on the depth and clarity of the paper. [See throughout the text.]

“Introduction”

Comment: Should identify more current statistics on worldwide rates of prostate cancer deaths.

Answer: We agree and added the required information and references. [See in Introduction]

Comment: It is unclear how “sociocultural realities that render prostate disease a taboo subject” is ameliorated or even considered in the context of this intervention.

Answer: We agree and removed this aspect from the manuscript.

Comment: It is also unclear how this intervention has the potential to impact limited knowledge of prostate disease that are often not seen until presented complicated or as advanced disease. This is not a community intervention on awareness, but rather a clinical intervention after clinical presentation.

Answer: We agree and make this distinction clear. We also broke down the results to referral groups. We further note in the revision that increasing the public awareness of prostate disease and improving the management of the disease (including patient-physician communication, the subject of this paper) must go hand in hand. [See in Discussion / Relationship to public awareness of prostate disease]

Comment: This authors must reconsider what is important to present as relevant background information for this study.

Answer: We agree and significantly revised the background. [See in Introduction]

Comment: Given the preliminary and exploratory nature of this study, this should be stated clearly upfront.

Answer: We agree and made clear the preliminary and exploratory nature of this study. We also changed the abstract to reflect this aspect. [See in Abstract and in Introduction]

“Methods”

Comment: Given the discussion of the 3D digital anatomy model section, it is unclear if a standard image was shown to all patients in the study, or if the image was personalized based on the individual patient case. It is unclear why there is a section on a specific patient case of a 62 year old man.

Answer: The MRI “image” was not personalized based on the individual patient case, and we clarify this important detail in the revision. [See in Methods]. We further note that in Senegal, there is a general lack of imaging capacity, especially of MRI. For future work, we consider creating several anatomical models, and based on a quick digital rectal examination, the physician could select the one that feels the most similar one to the prostate of the given patient. [See in Discussion / Limitations / Choice of the 3D anatomical model]

Comment: Under study design, authors indicate “patient first received … standard manual drawings, followed by … 3D digital…” What is the standard manual drawing based on? Is it just what the physician was able to draw themselves or a predrawn out image on a paper? More detail is needed for clarity.

Answer: In their “conventional patient-physician communication”, the participating physicians used didactic anatomical pictures of their own design and drawing, according to their own usual practice. We did not provide a “standardized” image or drawing. We clarified this in the revision. [See in Methods]

Comment: The questions are quite limited in nature and should be addressed in a limitations section.

Answer: We agree, with stressing, as the reviewer noted, that this was a single-arm prospective qualitative study of preliminary and exploratory nature. The questionnaires were purposefully designed to be simple and straightforward, for reasons we discuss in the revised text. [See in Discussion / Limitations / Choice of questionnaires]


Comment: What, if any, incentives were provided to study participants – whether patients or providers?

Answer: No specific incentives were offered to study participants, neither patients nor providers. During the informed consent process, however, patients were informed about potential benefits, such as receiving more detailed information about their disease and condition and additional “face time” with their consulting physician. We clarified this in the revision. [See in Methods]

“Results”

Comment: A comparison/usual care group could be much more informative and insightful, along with more detailed questions to assess quality of communication, understanding, communication skills, etc., even for low literacy groups, with low response burden.

Answer: We agree that a two-arm study and more nuanced questionnaires could be more informative – and these we intend to pursue in follow-up work outlined in the revised Discussion section. We reemphasize that the purpose of this study was to gauge the perception and generic practicality of 3D digital anatomical models, while keeping the questionnaire unburdening for all participants. [See in Discussion / Limitations / Study design and in Choice of questionnaires]

Comment: Authors should be more clear that the questions assess perception/perceived point of view. For example, asking about improved level of understanding as improved or declined, is perceived and not objective as asking actual questions that assess knowledge. This should also be acknowledged in a limitations section.

Answer: We agree and clarified the issue in the revision, stressing that this was a single-arm prospective qualitative study of exploratory nature, we chose to gauge the perception of the participants, rather than to assess their knowledge and experience gained through using of 3D digital anatomy models. We reserved this objective for future work [See in Discussion / Study Design]

“Discussion”

Comment: Authors should rephrase discussion section and conclusions drawn to be more accurate. For example, quality was not assessed and the conclusion that quality of communication improved is not accurate. There was no comparison group to show an improvement, nor a pre/post questionnaire, for example.

Answer: We agree and clarified in the revision: this was a single-arm prospective qualitative study of exploratory nature, in which we did not have different study arms to compare. We detail this among the Limitations in the revised Discussion session. [See in Discussion / Limitations / Study design and in Choice of questionnaires]

Comment: Impact on physicians – There is also extreme over simplification of communication skills. Nothing that was presented in the intervention dealt with communication – e.g., what is actually said/communicated to patients. This 3D image is a visual “tool” that has the potential to enhance communication, but that was not measured in this study, but rather participants’ perspective on usability or utility, and even that is quite limited in the 4 questions asked of patients and providers.

Answer: We agree and clarify in the revision, as the reviewer correctly noted earlier, that this was a preliminary and exploratory study, in which we did not intend to dwell in a quantitative analysis of such outcomes. The reviewer identifies an important objective for follow-up work that we outlined in the revised Discussion section. [See in Discussion / Limitations / Study design and in Choice of questionnaires]

Comment: Statistical significance – It is unclear why there is a section on statistical significance when this study was exploratory in nature and only presented descriptive statistics. This section seems inappropriate.

Answer: We agree and revised the statistical considerations accordingly. [See in Results / Statistical Considerations]

Comment: The additional subheadings following the discussion section is confusing, when some appear to be appropriate for the methods section.

Answer: We agree and revised the subheadings accordingly. [See in Discussion]

Comment: Digital software – what is the difference between the two platforms mentioned, besides one being free? Why bring this up as an option?

Answer: We intended to say that, for future work, there is now a newer and simpler free open-source digital anatomy platform that provides the same visual functionality as the software we used in this preliminary work. We clarified this in the revised Discussion section. [See in Discussion / Choice of digital anatomy viewing software]

Comment: The section on longevity of findings also seem inappropriate and inaccurate given the nature of this study.

Answer: We agree and arranged it into a subsection on Robustness of findings over time. [See in Discussion / Robustness of findings over time]

Reviewer 3

The changes addressing these comments are marked by blue color in the revised manuscript.

Comment: The manuscript represent the result of a survey on the use of a 3D digital anatomy model in urology consultation to reflect its effect on improving the communication of physician and patients. An interesting model used in this study which based on the results of the survey demonstrated an improved communication between physicians and patients. However, I do not believe the survey results are presented and discussed properly. in more detail (e.g.consider results in referral groups and).

Answer: We agree, and we carried out substantial revisions to address the issues raised by the reviewer, with emphasizing that this was a single-arm prospective qualitative study of preliminary and exploratory nature. We increased the depth of the presentation of Results and Discussion. [See in Results and in Discussion].

Comment. It is not clear if patients information such as age is collected in the survey. If it has been collected, the results should be reported and investigated in terms of any association with age groups (e.g. elderly patients might gain less benefit from the technology compared to younger patients). Otherwise, it should be mentioned that age of patients are not recorded in survey with a discussion on the reason.

Answer: Patient demographics was not collected in this study. We include this clarification in the revised manuscript. [See in Methods / Study Design and in Discussion / Impact on patients]

Comment: There is no statistical method applied to investigate the result of the survey. Authors need to apply statistical methods to add the uncertainty associated with the reported percentage (e.g. in terms of confidence intervals).

Answer: We agree, and we extended the statistical analysis in the Results section with confidence intervals in both Tables 1 and 2. [See in Results / Answers to the questionnaires]

Comment: Chi‐square or other relevant tests should be applied to investigate the association of each questionary with available patient groups (referral group, age groups, etc). [The] authors need to report results of the questionaries in the survey by the referral groups and investigate any association between referral groups and each questionary (e.g. different treatment usually are recommended for patients with different group so it would be interesting to consider how patients’ decision has changed regarding their referral group).

Answer: We agree, and in the revised paper we break down the results by various referral groups and analysed the results. Chi-square test of independence was performed to analyze the relation between referral groups and different responses in the questionnaire. Bonferroni correction was applied to compensate for repeated tests. [See in Table 3, in Results, and in Discussion / Impact on Patients].

Comment: Impact on patients in discussion, it is mentioned that “A tool that facilitates the communication and understanding of prostate diseases could be beneficial in improving the quality of care and reducing healthcare costs”. However, it is not well discussed how such a tool could reduce healthcare cost, and I suggest authors to add a discussion justifying this (lines 168‐170)

Answer: We agree and added the required discussion. [See in Introduction]

Comment: They mentioned that the use of such a 3D digital anatomy model is helpful for treatment decision of high‐risk patients. It is not clear how the presented results are supporting such a statement! A clear discussion needs to be added including how the patients decisions are improved by use of such a 3D digital anatomy model.

Answer: We agree and in the revised paper, in Table 3, we break down the results by referral groups including the “high-risk” patient groups. Patients favored the digital model regardless of the referral group, the differences were much more significant in decision-making for “high-risk” patient groups who needed immediate management or treatment of the disease. [See in Table 3 and in Discussion / Impact on Patients].

Comment: Some of subsections in the discussion should be moved and presented in the Method section (i.e. Statistical significance, Choice of questionnaires and Choice of digital anatomy viewing software).

Answer: We agree, and we carried out substantial editorial revisions. We moved “Statistical considerations” to the Results section. At the same time, we kept in the Discussion under Limitations the subheadings on “Choice of questionnaires” and “Choice of digital anatomy viewing software”; we deem these necessary to properly discuss limitations of the study. [See in Results and Discussion/Limitations]

Comment: It is not clear how such a software would be available to be used in the clinical practices if required.

Answer: We included a brief discussion of this issue. [See in Discussion / Limitations / Choice of Choice of digital anatomy viewing software]

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Yann Benetreau

27 Oct 2022

The use of 3D digital anatomy model improves the quality of communication with patients presenting with prostate disease : first experience in Senegal

PONE-D-21-12063R1

Dear Dr. Diao,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yann Benetreau

Staff Editor

PLOS ONE

Additional Editor Comments (optional):

Please note reviewer 3's last request, which you may address in your final version.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #3: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #3: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #3: In the revised version, the authors substantially improved the presentation of results and discussion. I find the revised version addresses my points, and I only have one minor comment:

While I find Table 3 informative and discussed its results well, I suggest that all chi-square test p-values be reported (regardless of whether they are statistically significant).

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: No

**********

Acceptance letter

Yann Benetreau

8 Nov 2022

PONE-D-21-12063R1

The use of 3D digital anatomy model improves the communication with patients presenting with prostate disease: the first experience in Senegal

Dear Dr. Diao:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yann Benetreau

Staff Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data

    (XLS)

    S2 Data

    (XLS)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES